pharmacopeia

Visual Impairment

74 drugs32,516 FAERS reportsMedDRA PT
GET
/api/v1/reaction/visual-impairment
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D015354

Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.).

Source: U.S. National Library of Medicine — MeSH (Vision, Low)

Drugs reporting Visual Impairment (74)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Klebsiella Pneumoniae1100%
  2. 2Aceclidine14835%
  3. 3Triclosan15932%
  4. 4Estriol36322%
  5. 5Lithium Chloride420%
  6. 6Revakinagene Taroretcel120%
  7. 7Medronate117%
  8. 8Brolucizumab56716%
  9. 9Hypromellose 2910114%
  10. 10Gramicidin113%
  11. 11Pegcetacoplan1358.0%
  12. 12Voretigene Neparvovec127.9%
  13. 13Iodoquinol37.9%
  14. 14Faricimab5687.8%
  15. 15Chloramphenicol27.1%
  16. 16Avacincaptad Pegol186.9%
  17. 17Aflibercept2,0946.6%
  18. 18Pilocarpine2046.2%
  19. 19Ranibizumab1,6366.2%
  20. 20Tropicamide845.2%
  21. 21Sertaconazole85.2%
  22. 22Methazolamide164.9%
  23. 23Polysorbate 80544.9%
  24. 24Cyclopentolate334.7%
  25. 25Perfluorohexyloctane724.4%
  26. 26Belantamab1194.3%
  27. 27Belantamab Mafodotin1194.3%
  28. 28Lixisenatide1434.2%
  29. 29Sofpironium84.2%
  30. 30Difluprednate1544.1%
  31. 31Insulin Lispro5,5394.0%
  32. 32Latanoprostene Bunod393.9%
  33. 33Nepafenac1233.9%
  34. 34Avutometinib203.8%
  35. 35Defactinib203.8%
  36. 36Ethynodiol63.8%
  37. 37Tetracaine233.7%
  38. 38Insulin Glargine8,8043.6%
  39. 39Lifitegrast5723.6%
  40. 40Proparacaine183.5%
  41. 41Loteprednol2013.5%
  42. 42Loteprednol Etabonate2013.5%
  43. 43Povidone-iodine1363.3%
  44. 44Mirvetuximab Soravtansine483.3%
  45. 45Crizotinib4043.2%
  46. 46Povidone2563.2%
  47. 47Brinzolamide3853.1%
  48. 48Siponimod2693.1%
  49. 49Fingolimod2,6193.0%
  50. 50Polyvinyl Alcohol1192.9%
  51. 51Besifloxacin282.9%
  52. 52Carboxymethylcellulose3642.9%
  53. 53Netarsudil752.8%
  54. 54Trametinib6052.6%
  55. 55Travoprost2162.5%
  56. 56Dabrafenib5202.5%
  57. 57Pheniramine452.4%
  58. 58Cenegermin2792.3%
  59. 59Binimetinib1742.3%
  60. 60Timolol7962.2%
  61. 61Propylene1442.2%
  62. 62Propylene Glycol1442.2%
  63. 63Pentosan Polysulfate1502.2%
  64. 64Dorzolamide3662.2%
  65. 65Trypan Blue12.2%
  66. 66Hyaluronate172.2%
  67. 67Insulin Degludec4952.1%
  68. 68Latanoprost1,0322.0%
  69. 69Encorafenib1892.0%
  70. 70Acoltremon491.8%
  71. 71Tafluprost501.7%
  72. 72Vigabatrin1711.2%
  73. 73Bromfenac73—
  74. 74Brilliant Blue G3—

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Vision, Low as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients